China Botanic Pharmaceutical (CBP) Reports Q3 EPS of $0.09

China Botanic Pharmaceutical (NYSE: CBP) reported Q3 EPS of $0.09, versus $0.07 reported last year. Revenue for the quarter came in at $15.08 million, versus $12.38 million reported last year.

For earnings history and earnings-related data on China Botanic Pharmaceutical (CBP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• The post-earnings selloff has created a buying opportunity in this stock - Argus
• Morgan Stanley on Boeing (BA): 'We expect the company to provide additional feedback'